|
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
Abacavir (as abacavir sulfate) 600 mg and dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet
Id1079891000202103
StatusDefined
Has manufactured dose formOral tablet
Has unit of presentationTablet
Has BoSSLamivudine
Has precise active ingredientLamivudine
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSabacavir
Has precise active ingredientAbacavir sulfate
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSDolutegravir
Has precise active ingredientDolutegravir sodium
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg